News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
14,134 Results
Type
Article (796)
Company Profile (19)
Press Release (13319)
Section
Business (4615)
Career Advice (17)
Deals (671)
Drug Delivery (2)
Drug Development (2516)
Employer Resources (2)
FDA (302)
Job Trends (342)
News (7649)
Policy (421)
Tag
Academia (38)
Adcomms (3)
Allergies (5)
Alliances (1242)
ALS (1)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (9)
Approvals (295)
Artificial intelligence (7)
Bankruptcy (6)
Best Places to Work (289)
BIOSECURE Act (5)
Biosimilars (1)
Biotechnology (15)
Bladder cancer (1)
Cancer (60)
Cardiovascular disease (7)
Career advice (10)
CAR-T (9)
Cell therapy (31)
Clinical research (1962)
Collaboration (35)
Compensation (18)
COVID-19 (105)
CRISPR (4)
C-suite (11)
Cystic fibrosis (1)
Data (64)
Diabetes (3)
Diagnostics (38)
Drug discovery (2)
Drug pricing (1)
Earnings (1486)
Editorial (2)
Employer resources (2)
Events (2565)
Executive appointments (37)
FDA (336)
Funding (33)
Gene editing (8)
Gene therapy (20)
GLP-1 (21)
Government (55)
Guidances (2)
Healthcare (402)
Immunology and inflammation (6)
Indications (1)
Infectious disease (106)
Inflammatory bowel disease (8)
Intellectual property (4)
Interviews (3)
IPO (368)
Job creations (62)
Job search strategy (10)
Kidney cancer (1)
Labor market (4)
Layoffs (14)
Legal (69)
Liver cancer (1)
Lung cancer (6)
Lymphoma (11)
Machine learning (1)
Management (1)
Manufacturing (10)
MASH (1)
Medical device (124)
Medtech (124)
Mergers & acquisitions (318)
Metabolic disorders (7)
Neurodegenerative disease (5)
Neuroscience (19)
NextGen: Class of 2025 (149)
Non-profit (21)
Now hiring (1)
Obesity (3)
Opinion (1)
Ovarian cancer (1)
Pain (7)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (13)
Patient recruitment (4)
People (1722)
Pharmacy benefit managers (1)
Phase I (825)
Phase II (905)
Phase III (666)
Pipeline (40)
Policy (10)
Postmarket research (33)
Preclinical (276)
Press Release (2)
Prostate cancer (2)
Radiopharmaceuticals (2)
Rare diseases (7)
Real estate (112)
Recruiting (1)
Regulatory (359)
Reports (3)
Research institute (63)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (3)
Series A (11)
Series B (3)
Service/supplier (1)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (2)
Startups (108)
Supply chain (2)
Tariffs (2)
Vaccines (12)
Weight loss (1)
Date
Last 7 days (29)
Last 30 days (94)
Last 365 days (1030)
2025 (364)
2024 (1123)
2023 (1347)
2022 (1722)
2021 (1734)
2020 (1332)
2019 (810)
2018 (595)
2017 (728)
2016 (578)
2015 (628)
2014 (431)
2013 (367)
2012 (320)
2011 (322)
2010 (328)
Location
Africa (14)
Asia (1107)
Australia (91)
California (313)
Canada (88)
China (20)
Colorado (2)
Connecticut (8)
Delaware (5)
Europe (1461)
Florida (19)
Georgia (7)
Idaho (1)
Illinois (11)
India (1)
Indiana (2)
Japan (5)
Maine (1)
Maryland (48)
Massachusetts (134)
Michigan (2)
Minnesota (4)
New Jersey (52)
New Mexico (1)
New York (25)
North Carolina (14)
Northern California (120)
Ohio (2)
Oklahoma (1)
Pennsylvania (51)
South America (9)
Southern California (109)
Tennessee (1)
Texas (21)
United States (729)
Utah (5)
Washington D.C. (2)
Washington State (10)
Wisconsin (1)
14,134 Results for "axial biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis
April 16, 2025
·
1 min read
Press Releases
Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis
April 16, 2025
·
3 min read
Press Releases
Augurex Announces UKCA Authorization for SPINEstat™, Expanding Access to a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis to Great Britain
April 23, 2025
·
3 min read
BioMidwest
UCB to share first presentations of BIMZELX® (bimekizumab-bkzx) two-year data in axial spondyloarthritis and psoriatic arthritis at EULAR 2024
UCB announced the first presentation of two-year data from the Phase 3 studies, BE MOBILE 1 and BE MOBILE 2, and the open-label extension, BE MOVING, evaluating BIMZELX, an interleukin -17A and IL-17F inhibitor, in the treatment of active non-radiographic axial spondyloarthritis and ankylosing spondylitis, also known as radiographic axial spondyloarthritis.
June 12, 2024
·
21 min read
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Augurex to Present Axial Spondyloarthritis Data and Exhibit at ACR Convergence 2024 in Washington, DC
November 7, 2024
·
3 min read
Genetown
Axial Therapeutics to Present at Upcoming Conferences - Jan 05, 2024
Axial Therapeutics announced that A. Stewart Campbell, PhD, Chief Executive Officer, will participate in the following upcoming conferences.
January 5, 2024
·
1 min read
Press Releases
Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)
May 5, 2025
·
6 min read
Press Releases
Interius BioTherapeutics to Present at Upcoming Scientific Meetings
April 17, 2025
·
2 min read
Press Releases
Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
April 24, 2025
·
3 min read
1 of 1,414
Next
